Evidence map›Paper›PMID 37901116›Full record

ReviewThe journal of venomous animals and toxins including tropical diseases2023

Research advances in the degradation of aflatoxin by lactic acid bacteria.

Yuxi Wang, Lishi Jiang, Ying Zhang, Ran Ran, Xiao Meng, Shukun Liu

Abstract readReview
In one paragraph

Review in The journal of venomous animals and toxins including tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. LGG/LAC-MMT combination mitigates AFBFrontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxi WangInstitute of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Lishi JiangInstitute of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ying ZhangInstitute of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ran RanSchool of Light Industry and Materials, Chengdu Textile College, Chengdu, China.
Xiao MengInstitute of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.ORCID 0000-0003-2101-9483
Shukun LiuInstitute of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aflatoxins are toxic secondary metabolites that often contaminate food and animal feed, causing huge economic losses and serious health hazards. Aflatoxin contamination has become a major concern worldwide. Biological methods have been used to reduce aflatoxins in food and feed by inhibiting toxin production and detoxification. Among biological methods, lactic acid bacteria are of significant interest because of their safety, efficiency, and environmental friendliness. This study aimed to review the mechanisms by which lactic acid bacteria degrade aflatoxins and the factors that influence their degradation efficiency, including the action of the lactic acid bacteria themselves (cell wall adsorption) and the antifungal metabolites produced by the lactic acid bacteria. The current applications of lactic acid bacteria to food and feed were also reviewed. This comprehensive analysis provided insight into the binding mechanisms between lactic acid bacteria and aflatoxins, facilitating the practical applications of lactic acid bacteria to food and agriculture.

Indexed as

Aflatoxinsapplicationsbiodegradationlactic acid bacteriamechanism

Identifiers

PMID37901116
PMCPMC10601132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.